{"id":3894,"date":"2017-02-15T16:26:03","date_gmt":"2017-02-15T22:26:03","guid":{"rendered":"http:\/\/www.ismrm.org\/smrt\/?page_id=3894"},"modified":"2021-08-06T16:45:06","modified_gmt":"2021-08-06T23:45:06","slug":"2017-declaration","status":"publish","type":"page","link":"https:\/\/www.ismrm.org\/smrt\/2017-annual-meeting\/2017-online-program-book\/2017-declaration\/","title":{"rendered":"2017 Declaration"},"content":{"rendered":"
<\/div><\/div><\/div>

2017 Declaration of Relevant Financial Relationships<\/strong><\/h1>\n<\/div>
<\/div><\/div><\/div><\/div><\/div>

The SMRT is committed to:<\/p>\n

    \n
  1. Ensuring balance, independence, objectivity and scientific rigor in all Continuing Education programs, and<\/li>\n
  2. Presenting Continuing Education activities that promote improvements or quality in healthcare and are independent of commercial interests.<\/li>\n<\/ol>\n

    To ensure balance, independence, objectivity and scientific rigor in all Continuing Education programs it is the\npolicy of the SMRT that any person who has influence over the content of a program designated for Category A CE Credit or CPD must disclose any real or apparent financial interest or other relationship (i.e., grants, research support, consultant, honoraria) that the individual may have with the manufacturers, distributors, or providers of any commercial products or services that may be discussed in the presentation.<\/p>\n

    SMRT does not imply that such financial interests or relationships are inherently improper or that such interests or relationships would prevent the speaker from making an objective contribution. However, it is imperative that such financial interests or relationships be identified so that participants at the Continuing Education activity may have these facts fully disclosed in advance, and may form their own judgments about the presentations. It remains for the audience to determine whether an individual\u2019s outside interests may reflect a possible bias in either the exposition or the conclusions presented.<\/p>\n

    Following are the invited speaker names and whether or not there are conflicts. If individuals have disclosed real or apparent financial interests or relationships with regard to the subject matter of this meeting, the interests or relationships are described. If the individual indicated that there were no conflicts that is shown as well.<\/p>\n<\/div>

    <\/div><\/div><\/div><\/div><\/div>

    2017 SMRT Annual Meeting Invited Speakers:<\/strong><\/h2>\n<\/div>
    <\/div><\/div><\/div>
    \r\n\r\n\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t\r\n\t\t
    Bizzi, Alberto<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\t\u00a0<\/td>\r\n\t<\/tr>\r\n\t
    Carr, James<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tSiemens: Grant\/Research Support; Guerbet: Consultant; Bayer Healthcare Pharma\/Schering: Consultant; Circle: Consultant<\/td>\r\n\t<\/tr>\r\n\t
    Chin, Frederick<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Connelly, Alan<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\t\u00a0<\/td>\r\n\t<\/tr>\r\n\t
    Comeau, Cindy<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Culbreth, Luann<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\t\u00a0<\/td>\r\n\t<\/tr>\r\n\t
    Golsch, Amanda<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Grant, Patricia Ellen<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Graves, Martin<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Griswold, Mark<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\t\u00a0<\/td>\r\n\t<\/tr>\r\n\t
    Hernando, Diego<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Lee, Vivian<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    McRobbie, Donald<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tSiemens: Speakers Bureau, Lecturer on MR Physics in educational course run by company; Toshiba: Speakers Bureau, Lecturer on MR Physics in educational courses run by company; Eden Learning: Speakers Bureau, Lecturer on MR Physics in educational courses run by company<\/td>\r\n\t<\/tr>\r\n\t
    McWalter, Emily<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Moseley, Michael<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Muthurangu, Vivek<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Rajan, Sunder S.<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Schmierer, Klaus<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tHoffman-LaRoche: Consultant; Blizard Institute (Neuroscience): Consultant;
    \r\n\t\tQueen Mary University of London: Consultant; Teya: Consultant;
    \r\n\t\tMerck: Consultant
    \r\n\t\tOther Financial Interests \/ Relationships:
    \r\n\t\tPI of trials sponsored by Novartis, Roche, Teya and Medday
    \r\n\t\tInvolved in trials sponsored by Biogen, Genzyme, BIAL, Cytokinetics, Canbex
    \r\n\t\tSpeaking honoraria from, and\/or served in an advisory role for Biogen, Merck, Merck Inc., Novartis, Roche, Teya
    \r\n\t\tSupported by Genzyme to attend AAN 2014
    \r\n\t\tResearch grant support from Novartis, Biogen, National MS Society (US), MS Society of Great Britain & Northern Ireland, Royal College of Radiologists, and Barts Charity<\/td>\r\n\t<\/tr>\r\n\t
    Setsompop, Kawin<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tSiemens: Grant\/Research Support; General Electric: Patent Licensing; Philips: Patent Licensing; Samsung: Patent Licensing<\/td>\r\n\t<\/tr>\r\n\t
    Shellock, Frank G.<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Steckner, Michael<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tToshiba: Employment<\/td>\r\n\t<\/tr>\r\n\t
    Sunaert, Stephen<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\t\u00a0<\/td>\r\n\t<\/tr>\r\n\t
    Tong, Karen<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Totman, John<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    Witte, Robert J.<\/td>\r\n\t\t\u00a0<\/td>\r\n\t\tNo Conflict<\/td>\r\n\t<\/tr>\r\n\t
    \u00a0<\/td>\r\n\t<\/tr>\r\n<\/table>\r\n<\/td><\/tr><\/table>
    <\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":3779,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3894","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/pages\/3894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/comments?post=3894"}],"version-history":[{"count":4,"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/pages\/3894\/revisions"}],"predecessor-version":[{"id":9667,"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/pages\/3894\/revisions\/9667"}],"up":[{"embeddable":true,"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/pages\/3779"}],"wp:attachment":[{"href":"https:\/\/www.ismrm.org\/smrt\/wp-json\/wp\/v2\/media?parent=3894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}